Brussels, 03/07/2001 (Agence Europe) - The European Commission has taken a decision ordering IMS Health, the world leader in data collection on pharmaceutical sales and prescriptions, to licence its "1860 brick structure", which segments Germany into sales zones or "bricks". After careful analysis, the Commission considers that IMS' refusal to grant a licence for the use of the structure, which has become a national standard in the German pharmaceutical industry, constitutes a prima facie...